Skip to main content
Robert Levin, MD, Rheumatology, Clearwater, FL

RobertWilliamLevinMD

Rheumatology Clearwater, FL

Physician

Are you Dr. Levin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 66 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1831 N Belcher Rd
    Ste D2
    Clearwater, FL 33765
    Phone+1 727-734-6631
    Fax+1 727-736-0548

Summary

  • Dr. Robert Levin, MD is a rheumatologist in Clearwater, Florida. He is currently licensed to practice medicine in Florida and Pennsylvania. He is affiliated with Mease Countryside Hospital and Morton Plant Hospital.

Education & Training

  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalFellowship, Rheumatology, 1987 - 1989
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1984 - 1987
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1989 - 2025
  • PA State Medical License
    PA State Medical License 1986 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Press Mentions

  • Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class
    Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug ClassJune 24th, 2021
  • The ‘Great American Switching Experiment’: Cyltezo Debut Ushers in Interchangeable Era
    The ‘Great American Switching Experiment’: Cyltezo Debut Ushers in Interchangeable EraJuly 25th, 2023

Professional Memberships